Various parameters, including the aspartate transaminase (AST)-to-platelet ratio index (APRI) and fibrosis-4 index (FIB-4), which are derived from AST, alanine aminotransferase (ALT), and/or platelets, have been used to assess histologic change in NAFLD in previous studies on adults [6,7]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.